PeptidePedia The community reference

Special:RecentChanges

Change log·7,183 revisions·page 64 of 72

Every change to PeptidePedia Wiki, newest first. N marks a new page, m a minor edit and b an edit by an approved bot. The byte figure is the page size after the edit; the coloured figure is the change. 7,183 changes are logged in total.

7,183Logged changes
598Bot edits
175Page creations
256Active editors

12 October 2024

  1. (diff | hist) m b 11:01 Reverse-phase HPLC 3,045 ±0 StubSorterBot (talk | contribs) bot: flag bare reference [rollback]
  2. (diff | hist) m 07:31 Oral semaglutide 2,537 +408 LiraLotte (talk | contribs) give the INN alongside the trade name at first mention [rollback]
  3. (diff | hist) 05:44 Repackaging 2,063 +230 WeaselWordWim (talk | contribs) fix hyphenation per PP:MOS [rollback]
  4. (diff | hist) m 02:48 Test report forgery 1,322 ±0 IcodecIndra (talk | contribs) fix a dangling clause [rollback]

11 October 2024

  1. (diff | hist) 20:35 Amylin 2,565 +591 SurvodutideSaff (talk | contribs) expand §Amyloid formation [rollback]
  2. (diff | hist) N 19:11 Test report forgery 1,322 +1,322 FreightFenna (talk | contribs) new article: testing and documentation, expansion welcome
  3. (diff | hist) 17:02 Peptide aggregation 2,241 ±0 StateBoardStace (talk | contribs) add the equilibration time to the gradient description [rollback]
  4. (diff | hist) 16:53 Lixisenatide 1,771 +581 HOMA_Hettie (talk | contribs) correct the molar mass — source gives the free-base figure, we had the salt [rollback]
  5. (diff | hist) 15:26 Mass spectrometry 3,840 +812 COA_Colwyn (talk | contribs) add the plate-count expression and define its terms [rollback]
  6. (diff | hist) N 09:00 Dose escalation schedule 1,918 +1,918 EscalationEira (talk | contribs) create article — preparation and handling stub
  7. (diff | hist) 02:59 Certificate of analysis 3,859 +137 DiagramDelphine (talk | contribs) add the difference between a batch certificate and a lot-specific one [rollback]
  8. (diff | hist) m b 02:41 Bacterial endotoxin test 2,929 +505 CiteBot (talk | contribs) bot: normalise citation format [rollback]

10 October 2024

  1. (diff | hist) 17:29 Peptide 3,677 ±0 ReportReaderRilla (talk | contribs) correct the eutectic temperature — source gives a range [rollback]
  2. (diff | hist) 13:17 Lyophilisation 7,435 +2,804 LipidLedgerLou (talk | contribs) rm the blanket claim that excursions are harmless [rollback]
  3. (diff | hist) 11:14 International nonproprietary name 1,106 ±0 CagriCass (talk | contribs) de-duplicate a repeated sentence [rollback]
  4. (diff | hist) 10:28 Talk:Nantong Guangyuan Chemical 1,033 +129 ScopeSeverin (talk | contribs) /* Multiple trading names: which is the title? */ reply
  5. (diff | hist) m 01:55 LEADER trial 2,187 +223 ParentCatPansy (talk | contribs) add the number randomised and the number completing [rollback]
  6. (diff | hist) 01:25 Reconstitution calculator 2,683 +1,020 DrTitration (talk | contribs) add the cross-link from the calculator to the unit-conversion article [rollback]

9 October 2024

  1. (diff | hist) m 21:12 FLOW trial 1,950 +752 LotTraceLuka (talk | contribs) correct the endpoint hierarchy — that was a secondary endpoint [rollback]
  2. (diff | hist) 20:52 WuXi TIDES 4,593 +159 CPeptidePaddy (talk | contribs) rm the adjective — an organisation article describes, it does not praise [rollback]
  3. (diff | hist) m 20:28 Receptor bias 2,105 +167 ProglucagonPia (talk | contribs) give the fasting and postprandial concentrations with the assay named [rollback]
  4. (diff | hist) 10:30 Talk:Area percent purity 1,033 +105 Areapercent_Ayo (talk | contribs) /* The worked example — check the arithmetic */ reply
  5. (diff | hist) 09:52 Talk:Nantong Guangyuan Chemical 822 +201 SourceHunterSile (talk | contribs) /* Multiple trading names: which is the title? */ reply
  6. (diff | hist) N 09:00 International nonproprietary name 1,106 +1,106 PriorAuthPaz (talk | contribs) create article — compound stub
  7. (diff | hist) 06:42 Proglucagon 3,075 ±0 ReceptorRhoda (talk | contribs) rm a duplicated category [rollback]

8 October 2024

  1. (diff | hist) 23:17 Semaglutide 5,578 +567 SecretagogueSol (talk | contribs) state plainly that the research-use-only form is not approved for human use [rollback]
  2. (diff | hist) 22:34 Trifluoroacetate counterion 2,370 +272 LurkerLevi (talk | contribs) add the detection wavelength [rollback]
  3. (diff | hist) m 21:57 Fmoc chemistry 2,683 ±0 GlossaryGleb (talk | contribs) correct the humidity figure — relative humidity needs its temperature [rollback]
  4. (diff | hist) m b 21:43 Area percent purity 2,977 +369 CategoryBot (talk | contribs) bot: normalise unit spacing [rollback]
  5. (diff | hist) 20:17 Intention-to-treat analysis 2,691 +31 TrialsTabitha (talk | contribs) the trial was open-label; the article implied blinding [rollback]
  6. (diff | hist) 16:15 Chain of custody 2,673 +259 BatchNumberBede (talk | contribs) clarify that a QR code on a certificate proves issuance, not content [rollback]
  7. (diff | hist) 16:07 Arcuate nucleus 2,347 ±0 DiagramDelphine (talk | contribs) give the magnitude of the incretin effect as a percentage of the insulin response [rollback]
  8. (diff | hist) m 14:48 Resin cleavage 2,363 ±0 CounterfeitCato (talk | contribs) rm the shipping recommendation — that is advice, not description [rollback]
  9. (diff | hist) 14:37 Talk:Nantong Guangyuan Chemical 611 +249 INN_Ingrid (talk | contribs) /* Multiple trading names: which is the title? */ reply
  10. (diff | hist) 11:19 Talk:Nantong Guangyuan Chemical 400 +210 MoveRequestMio (talk | contribs) /* Multiple trading names: which is the title? */ new section
  11. (diff | hist) 08:52 Talk:Area percent purity 822 +162 LOD_Lorcan (talk | contribs) /* The worked example — check the arithmetic */ reply
  12. (diff | hist) m b 02:23 Reconstitution of lyophilised peptides 3,090 +129 CategoryBot (talk | contribs) bot: add stub category [rollback]
  13. (diff | hist) 01:34 Medutest 2,708 ±0 Peptide_Pete (talk | contribs) state the method the reporting service uses, since it is not the only one available [rollback]
  14. (diff | hist) N 00:25 Lixisenatide 1,190 +1,190 ColdChainCleo (talk | contribs) start article on the compound

7 October 2024

  1. (diff | hist) 17:33 VendorInvestigate 2,593 ±0 BlankVialBo (talk | contribs) state the method the reporting service uses, since it is not the only one available [rollback]
  2. (diff | hist) m b 15:47 Retatrutide 3,482 ±0 ArchiveBot (talk | contribs) bot: expand DOI to full citation [rollback]
  3. (diff | hist) 14:15 Talk:Area percent purity 611 +188 TFA_Counterion (talk | contribs) /* The worked example — check the arithmetic */ reply
  4. (diff | hist) 12:24 Blind sampling 3,109 +142 Chromatokid (talk | contribs) expand §How this wiki handles it [rollback]
  5. (diff | hist) 11:43 Timeline of incretin therapeutics 2,352 ±0 StopperingSteff (talk | contribs) add the excipient list from the labelling [rollback]
  6. (diff | hist) 09:41 Talk:Area percent purity 400 +201 Areapercent_Ayo (talk | contribs) /* The worked example — check the arithmetic */ new section
  7. (diff | hist) N 09:00 Placebo-adjusted effect 1,276 +1,276 DiagramDelphine (talk | contribs) create article — trial programme stub
  8. (diff | hist) 08:17 Injection site rotation 2,900 +745 TitrationTheo (talk | contribs) fix a broken wikilink [rollback]
  9. (diff | hist) 05:51 Batch number 2,494 ±0 BlindSampleBrid (talk | contribs) state the method the reporting service uses, since it is not the only one available [rollback]
  10. (diff | hist) 03:35 Subcutaneous injection 2,958 ±0 DrTitration (talk | contribs) give the worked example to two significant figures throughout [rollback]

6 October 2024

  1. (diff | hist) m 23:48 Bachem Holding (Suzhou) 1,692 ±0 Ref_Desk_Ron (talk | contribs) sentence case in headings per PP:MOS [rollback]
  2. (diff | hist) N 19:43 Peptide aggregation 2,241 +2,241 NewLabNell (talk | contribs) new article: analytical method, expansion welcome
  3. (diff | hist) 18:54 GLP-1 receptor agonist 6,120 +584 EndpointEnid (talk | contribs) correct the molar mass — source gives the free-base figure, we had the salt [rollback]
  4. (diff | hist) m 18:31 Peptide content 2,954 +425 FigureFerdinand (talk | contribs) add the ionisation mode to the mass-spectrometry description [rollback]
  5. (diff | hist) m b 16:58 SELECT trial 2,328 +28 CiteBot (talk | contribs) bot: expand PMID to full citation [rollback]
  6. (diff | hist) 16:25 Chinese Peptide Company 4,325 ±0 UnderfillUna (talk | contribs) expand §Corporate identity and history [rollback]
  7. (diff | hist) m b 15:01 Liraglutide 3,239 +135 CiteBot (talk | contribs) bot: add drug-class category [rollback]
  8. (diff | hist) 11:28 Number needed to treat 1,122 ±0 AnalyticalAnnie (talk | contribs) add the PMID [rollback]
  9. (diff | hist) 10:48 Exenatide 1,276 ±0 LiraLotte (talk | contribs) ce [rollback]
  10. (diff | hist) 10:29 Talk:Reconstitution calculator 1,244 +80 DrTitration (talk | contribs) /* Does this page cross the line into instruction? */ reply
  11. (diff | hist) m 06:56 Loss on drying 2,274 +37 PancreasPru (talk | contribs) split §Principle from §Practical limitations [rollback]
  12. (diff | hist) m 05:56 Haemoglobin A1c 2,574 ±0 ComparisonCato (talk | contribs) correct the reference interval — the source gives it for fasting samples [rollback]
  13. (diff | hist) m 04:55 Custom peptide synthesis 2,139 ±0 StopperingSteff (talk | contribs) fix a broken wikilink [rollback]
  14. (diff | hist) 04:49 GLP-1 receptor 4,864 +997 GIP_Genoveva (talk | contribs) typo [rollback]
  15. (diff | hist) 03:21 Incretin effect 4,803 +754 CapitalisationCaz (talk | contribs) correct the second-messenger pathway named in the lead [rollback]
  16. (diff | hist) m 00:41 Fasting insulin 1,662 ±0 DEXA_Dilys (talk | contribs) expand §Standardisation [rollback]

5 October 2024

  1. (diff | hist) m 21:03 Good manufacturing practice 2,439 +666 Chromatokid (talk | contribs) add the customs-detention point with its source [rollback]
  2. (diff | hist) 14:52 Talk:Reconstitution calculator 1,033 +195 UnitsUrsula (talk | contribs) /* Does this page cross the line into instruction? */ reply
  3. (diff | hist) 11:09 SURMOUNT trial programme 2,567 ±0 LeaderLoic (talk | contribs) rm the cross-trial comparison; the populations are not comparable [rollback]
  4. (diff | hist) 10:26 Amylin receptor agonist 1,601 ±0 MassSpecMarv (talk | contribs) add short description [rollback]
  5. (diff | hist) m b 10:07 Albumin binding half-life extension 2,821 +396 ArchiveBot (talk | contribs) bot: sort category members [rollback]
  6. (diff | hist) 09:17 Peptide supply chain 1,378 ±0 DrTitration (talk | contribs) correct the humidity figure — relative humidity needs its temperature [rollback]
  7. (diff | hist) m b 08:49 Dipeptidyl peptidase-4 3,295 ±0 CategoryBot (talk | contribs) bot: normalise citation format [rollback]
  8. (diff | hist) 08:45 Enteroendocrine L cell 3,351 +305 CDMO_Caradoc (talk | contribs) rm the causal claim about appetite — the cited work is associative [rollback]
  9. (diff | hist) 07:49 HOMA-IR 1,590 +177 LabRangeLindy (talk | contribs) add the body-composition measurement method to the comparison [rollback]
  10. (diff | hist) 07:25 Cagrilintide 2,406 +304 ComparisonCato (talk | contribs) British spelling per PP:MOS [rollback]
  11. (diff | hist) 05:42 Nantong Guangyuan Chemical 5,718 +681 DeletionDeb (talk | contribs) add the note that this wiki publishes no score and no league table [rollback]
  12. (diff | hist) 04:24 Analytical method validation 2,979 ±0 PeakShapePol (talk | contribs) expand §The characteristics [rollback]
  13. (diff | hist) m 01:25 Sterile water for injection 2,419 +393 DeadSpaceDot (talk | contribs) expand §Compendial requirements [rollback]
  14. (diff | hist) 00:48 PeptideMeter 2,760 +33 MassSpecMarv (talk | contribs) give the fields a compendially-complete certificate would carry [rollback]

4 October 2024

  1. (diff | hist) 19:55 Wuhan Wansheng Biotechnology 6,078 +532 DrTitration (talk | contribs) expand §Ordering and availability [rollback]
  2. (diff | hist) N 17:50 Peptide supply chain 1,378 +1,378 TrialsTabitha (talk | contribs) start article on the process step
  3. (diff | hist) 17:08 SURPASS trial programme 2,611 ±0 TrialsTabitha (talk | contribs) rm a duplicated category [rollback]
  4. (diff | hist) 16:23 Hunan Aslsen Technology 2,616 +610 AnalyticalAnnie (talk | contribs) correct the trading name — the short code and the legal name are different things [rollback]
  5. (diff | hist) 14:08 Sterility testing 1,908 ±0 AnalyticalAnnie (talk | contribs) add the plate-count expression and define its terms [rollback]
  6. (diff | hist) 12:57 Research use only 3,527 ±0 TechnicianTeal (talk | contribs) correct the description of the research-use-only exemption [rollback]
  7. (diff | hist) 11:55 Liquid chromatography-mass spectrometry 2,132 ±0 BlindSampleBrid (talk | contribs) state that ultraviolet response is not uniform across impurities [rollback]
  8. (diff | hist) m 11:26 Prescribing information 2,203 +272 Peptide_Pete (talk | contribs) attribute the survey figure to the survey and give its sample size [rollback]
  9. (diff | hist) m 10:51 Cold chain 11,290 +477 FmocFrancis (talk | contribs) rm the blanket claim that excursions are harmless [rollback]
  10. (diff | hist) 08:58 Dual incretin agonist 3,231 ±0 API_Aurora (talk | contribs) add see also to the amylin analogue [rollback]
  11. (diff | hist) 06:27 List of GLP-1 receptor agonists 2,257 ±0 PortalPolly (talk | contribs) de-duplicate a repeated sentence [rollback]

3 October 2024

  1. (diff | hist) m b 18:47 Preparative HPLC purification 2,696 +388 StubSorterBot (talk | contribs) bot: normalise unit spacing [rollback]
  2. (diff | hist) 17:01 Certificate of analysis 3,722 +236 HarmReductionHen (talk | contribs) convert a hard-coded date to the house format [rollback]
  3. (diff | hist) 14:23 Triple agonist 2,043 ±0 NPOV_Nadia (talk | contribs) add the receptor targets to the lead sentence [rollback]
  4. (diff | hist) 11:29 Vial 9,207 +1,409 ResinRhoswen (talk | contribs) expand §Delamination and glass defects [rollback]
  5. (diff | hist) 08:07 Talk:Reconstitution calculator 822 +271 Ref_Desk_Ron (talk | contribs) /* Does this page cross the line into instruction? */ reply
  6. (diff | hist) m 05:46 Guangzhou JEEP Biotechnology 5,372 +729 DeadSpaceDot (talk | contribs) add the storage and handling guidance the organisation publishes [rollback]

2 October 2024

  1. (diff | hist) m b 20:19 Peptide synthesis 2,919 ±0 CategoryBot (talk | contribs) bot: flag bare reference [rollback]
  2. (diff | hist) m 19:13 Crude peptide 1,870 ±0 FmocFrancis (talk | contribs) add the note that lyophilised material tolerates excursions better than solution [rollback]
  3. (diff | hist) 18:39 Repackaging 1,833 ±0 DiagramDelphine (talk | contribs) expand §Environmental exposure during transfer [rollback]
  4. (diff | hist) m 12:40 High-performance liquid chromatography 3,326 ±0 Areapercent_Ayo (talk | contribs) expand §Why method conditions must be stated [rollback]